48 related articles for article (PubMed ID: 20428760)
1. Adrenomedullin antagonist suppresses tumor formation in renal cell carcinoma through inhibitory effects on tumor endothelial cells and endothelial progenitor mobilization.
Tsuchiya K; Hida K; Hida Y; Muraki C; Ohga N; Akino T; Kondo T; Miseki T; Nakagawa K; Shindoh M; Harabayashi T; Shinohara N; Nonomura K; Kobayashi M
Int J Oncol; 2010 Jun; 36(6):1379-86. PubMed ID: 20428760
[TBL] [Abstract][Full Text] [Related]
2. KLK10 derived from tumor endothelial cells accelerates colon cancer cell proliferation and hematogenous liver metastasis formation.
Kato K; Noda T; Kobayashi S; Sasaki K; Iwagami Y; Yamada D; Tomimaru Y; Takahashi H; Uemura M; Asaoka T; Shimizu J; Doki Y; Eguchi H
Cancer Sci; 2024 May; 115(5):1520-1535. PubMed ID: 38475666
[TBL] [Abstract][Full Text] [Related]
3. Adrenomedullin is a cross-talk molecule that regulates tumor and mast cell function during human carcinogenesis.
Zudaire E; Martínez A; Garayoa M; Pío R; Kaur G; Woolhiser MR; Metcalfe DD; Hook WA; Siraganian RP; Guise TA; Chirgwin JM; Cuttitta F
Am J Pathol; 2006 Jan; 168(1):280-91. PubMed ID: 16400030
[TBL] [Abstract][Full Text] [Related]
4. Aberrant tumor vasculature. Facts and pitfalls.
Ribatti D
Front Pharmacol; 2024; 15():1384721. PubMed ID: 38576482
[TBL] [Abstract][Full Text] [Related]
5. Communicator Extraordinaire: Extracellular Vesicles in the Tumor Microenvironment Are Essential Local and Long-Distance Mediators of Cancer Metastasis.
Mitchell MI; Loudig O
Biomedicines; 2023 Sep; 11(9):. PubMed ID: 37760975
[TBL] [Abstract][Full Text] [Related]
6. Peptidergic Systems and Cancer: Focus on Tachykinin and Calcitonin/Calcitonin Gene-Related Peptide Families.
Sánchez ML; Rodríguez FD; Coveñas R
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980580
[TBL] [Abstract][Full Text] [Related]
7. Extracellular Vesicles: New Classification and Tumor Immunosuppression.
Sheta M; Taha EA; Lu Y; Eguchi T
Biology (Basel); 2023 Jan; 12(1):. PubMed ID: 36671802
[TBL] [Abstract][Full Text] [Related]
8. Gel-forming antagonist provides a lasting effect on CGRP-induced vasodilation.
Chang CL; Cai Z; Hsu SYT
Front Pharmacol; 2022; 13():1040951. PubMed ID: 36569288
[TBL] [Abstract][Full Text] [Related]
9. Novel antiangiogenic therapy targeting biglycan using tumor endothelial cell-specific liposomal siRNA delivery system.
Maishi N; Sakurai Y; Hatakeyama H; Umeyama Y; Nakamura T; Endo R; Alam MT; Li C; Annan DA; Kikuchi H; Morimoto H; Morimoto M; Akiyama K; Ohga N; Hida Y; Harashima H; Hida K
Cancer Sci; 2022 May; 113(5):1855-1867. PubMed ID: 35266253
[TBL] [Abstract][Full Text] [Related]
10. Heparanase and the hallmarks of cancer.
Jayatilleke KM; Hulett MD
J Transl Med; 2020 Nov; 18(1):453. PubMed ID: 33256730
[TBL] [Abstract][Full Text] [Related]
11. Development of chimeric and bifunctional antagonists for CLR/RAMP receptors.
Chang CL; Hsu SYT
PLoS One; 2019; 14(5):e0216996. PubMed ID: 31150417
[TBL] [Abstract][Full Text] [Related]
12. Complex interplay between tumor microenvironment and cancer therapy.
Shen M; Kang Y
Front Med; 2018 Aug; 12(4):426-439. PubMed ID: 30097962
[TBL] [Abstract][Full Text] [Related]
13. Contribution of Tumor Endothelial Cells in Cancer Progression.
Hida K; Maishi N; Annan DA; Hida Y
Int J Mol Sci; 2018 Apr; 19(5):. PubMed ID: 29695087
[TBL] [Abstract][Full Text] [Related]
14. Roles of circulating endothelial progenitor cells and endothelial cells in gastric carcinoma.
Li B; Nie Z; Zhang D; Wu J; Peng B; Guo X; Shi Y; Cai X; Xu L; Cao F
Oncol Lett; 2018 Jan; 15(1):324-330. PubMed ID: 29391882
[TBL] [Abstract][Full Text] [Related]
15. Expression of adrenomedullin in rats after spinal cord injury and intervention effect of recombinant human erythropoietin.
Zhao L; Jing Y; Qu L; Meng X; Cao Y; Tan H
Exp Ther Med; 2016 Dec; 12(6):3680-3684. PubMed ID: 28101163
[TBL] [Abstract][Full Text] [Related]
16. Tumour endothelial cells in high metastatic tumours promote metastasis via epigenetic dysregulation of biglycan.
Maishi N; Ohba Y; Akiyama K; Ohga N; Hamada J; Nagao-Kitamoto H; Alam MT; Yamamoto K; Kawamoto T; Inoue N; Taketomi A; Shindoh M; Hida Y; Hida K
Sci Rep; 2016 Jun; 6():28039. PubMed ID: 27295191
[TBL] [Abstract][Full Text] [Related]
17. Tumor angiogenesis--characteristics of tumor endothelial cells.
Hida K; Maishi N; Torii C; Hida Y
Int J Clin Oncol; 2016 Apr; 21(2):206-212. PubMed ID: 26879652
[TBL] [Abstract][Full Text] [Related]
18. Adrenomedullin and tumour microenvironment.
Larráyoz IM; Martínez-Herrero S; García-Sanmartín J; Ochoa-Callejero L; Martínez A
J Transl Med; 2014 Dec; 12():339. PubMed ID: 25475159
[TBL] [Abstract][Full Text] [Related]
19. HIFs enhance the transcriptional activation and splicing of adrenomedullin.
Sena JA; Wang L; Pawlus MR; Hu CJ
Mol Cancer Res; 2014 May; 12(5):728-41. PubMed ID: 24523299
[TBL] [Abstract][Full Text] [Related]
20. Lysyl oxidase secreted by tumour endothelial cells promotes angiogenesis and metastasis.
Osawa T; Ohga N; Akiyama K; Hida Y; Kitayama K; Kawamoto T; Yamamoto K; Maishi N; Kondoh M; Onodera Y; Fujie M; Shinohara N; Nonomura K; Shindoh M; Hida K
Br J Cancer; 2013 Oct; 109(8):2237-47. PubMed ID: 24045659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
